Jackmup-logo

 

                                                                                                                                   

Email:info@jackmup.com

Tel:+91 7219394600

googleplus facebook twitter linkedin
Erlonat

Specifications

 GENERIC NAME:- Erlotinib
 COMPANY:- Natco Pharma
 STRENGTH:- 150 mg/100 mg
 PACKING:- 1×30
 TYPE:- Tablet
 USES:- Anti-Cancer
 Description:-Erlonat tablet is used in the treatment of pancreatic cancer, small cell lung cancer, liver cancer, kidney cancer, thyroid cancer, blood cancer (chronic myeloid leukaemia), gastrointestinal stromal tumour, cancer of colon and rectum, non-small cell lung cancer, soft tissue sarcoma (cancer of soft tissue), chronic idiopathic myelofibrosis and breast cancer.Erlonat 150mg tablet In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Erlonat 150mg tablet blocks this signal, and thus stops the production of these cancer cells. Some precautions to be taken: Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food. Erlotinib is not recommended for children and adolescents under 18 years of age. Stop smoking and use effective contraceptive measures while on erlotinib treatment. Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert’s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding. Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.

Make an Enquiry


Believe in Us , Believe in Good Health !!!